Scribd
Upload
5 views

Presentation (5)

NHL

Uploaded by

milkbikis88
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
5 views

Presentation (5)

NHL

Uploaded by

milkbikis88
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 8

Bhalwanti

3rd year mbbs


Objective- NON HODGKIN
LYMPHOMA
• Investigation
• Management
• Prognosis
Investigation

• CBC – low blood count, Lymphocytosis,Thromocytosis.


• ESR level raised.
• Renal function test are required to ensure function is normal prior to treatment.
• Liver function test may be abnormal in the absence of disease.
• Chest x-ray may show mediastinum mass.
• CT scan of chest ,abdomen and pelvis permit staging.
• PET scan identify for node involvement.
• Bone marrow aspiration –to Identify bone marrow involvement.
Cont..

• Immunophenotyping of surface antigen to distinguish T cell from B cell tumor.


• Cytogenetic analysis to detect chromosomal translocation.
• Immunoglobulin determination.
• Measurement of uric acid level-high grads (NHL) associate with very high urate
level .
• HIV testing.
• Hepatitis B and C testing.
Management..

• Low grade NHL


• Radiotherapy: This can be used to localised stage l disease.
• Chemotherapy: most patient will respond to oral therapy with chlorambucil
which is well tolerated but not curative.
• Monoclonal antibody therapy humanised Monoclonal antibody can be used to
target surface antigen on tumor cells. Commonly used R-CHOP or R-
bendamustine are first line therapy.
• Kinase inhibitor :Idelalisib for relapsed follicular lymphoma
• :Ibrutinib for relapsed mantle cell lymphoma.
• Transplantation.
• High grade NHL
• Chemotherapy: the majority (>90%) are treated with intravenous combination
Chemotherapy. Eg: typically with the CHOP regimen .
• Monoclonal antibody therapy: when combined with CHOP therapy, Rituximab
improve overall survival .
• Radiotherapy: is indicated for residual localised site for bulk disease after
Chemotherapy.
• Autologous HSCT benefits patient with relapse disease.
Prognosis...

- Low grade NHL runs an indolent remitting and relapsing course ,with an overall
survival of 12 yrs . Tranform to a high grade NHL occur in 3 % per annum
associate with poor survival .
- The prognosis for patient with NHL is further refined according to the
international prognostic index (IPI) .For high grade NHL ,5 Year survival from
over 70 %in those with Low risk score (age <60 Yr, stage l or ll ,normal LDH )to
25% in those with high risk score .
- Relapse is associated with a poor response with further chemotherapy, but in
patient under 65 yrs HSCT improve survival.

You might also like